189 related articles for article (PubMed ID: 21321482)
1. Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections.
Mihu MR; Martinez LR
Virulence; 2011; 2(2):97-102. PubMed ID: 21321482
[TBL] [Abstract][Full Text] [Related]
2. Importation of multidrug-resistant Acinetobacter spp infections with casualties from Iraq.
Jones A; Morgan D; Walsh A; Turton J; Livermore D; Pitt T; Green A; Gill M; Mortiboy D
Lancet Infect Dis; 2006 Jun; 6(6):317-8. PubMed ID: 16728314
[No Abstract] [Full Text] [Related]
3. AB569, a non-toxic combination of acidified nitrite and EDTA, is effective at killing the notorious Iraq/Afghanistan combat wound pathogens, multi-drug resistant Acinetobacter baumannii and Acinetobacter spp.
Bogue AL; Panmanee W; McDaniel CT; Mortensen JE; Kamau E; Actis LA; Johannigman JA; Schurr MJ; Satish L; Kotagiri N; Hassett DJ
PLoS One; 2021; 16(3):e0247513. PubMed ID: 33657146
[TBL] [Abstract][Full Text] [Related]
4. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
Motaouakkil S; Charra B; Hachimi A; Benslama A
Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
[No Abstract] [Full Text] [Related]
5. Are we closing in on an "elusive enemy"? The current status of our battle with Acinetobacter baumannii.
Perez F; Ponce-Terashima R; Adams MD; Bonomo RA
Virulence; 2011; 2(2):86-90. PubMed ID: 21499025
[No Abstract] [Full Text] [Related]
6. Confronting multidrug-resistant Acinetobacter baumannii: a review.
Neonakis IK; Spandidos DA; Petinaki E
Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
[TBL] [Abstract][Full Text] [Related]
7. Acinetobacter baumannii resistant to everything: what should we do?
Vila J; Pachón J
Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
[No Abstract] [Full Text] [Related]
8. [Nosocomial pneumonia due to Acinetobacter baumannii].
Cisneros-Herreros JM; Garnacho-Montero J; Pachón-Ibáñez ME
Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():46-51. PubMed ID: 16854341
[TBL] [Abstract][Full Text] [Related]
9. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
[TBL] [Abstract][Full Text] [Related]
10. Global challenge of multidrug-resistant Acinetobacter baumannii.
Perez F; Hujer AM; Hujer KM; Decker BK; Rather PN; Bonomo RA
Antimicrob Agents Chemother; 2007 Oct; 51(10):3471-84. PubMed ID: 17646423
[No Abstract] [Full Text] [Related]
11. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.
Dijkshoorn L; Nemec A; Seifert H
Nat Rev Microbiol; 2007 Dec; 5(12):939-51. PubMed ID: 18007677
[TBL] [Abstract][Full Text] [Related]
12. [Multidrug-resistant Acinetobacter baumannii infection in respiratory intensive care unit].
Bacakoğlu F; Korkmaz Ekren P; Taşbakan MS; Başarik B; Pullukçu H; Aydemir S; Gürgün A; Başoğlu OK
Mikrobiyol Bul; 2009 Oct; 43(4):575-85. PubMed ID: 20084910
[TBL] [Abstract][Full Text] [Related]
13. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq.
Scott P; Deye G; Srinivasan A; Murray C; Moran K; Hulten E; Fishbain J; Craft D; Riddell S; Lindler L; Mancuso J; Milstrey E; Bautista CT; Patel J; Ewell A; Hamilton T; Gaddy C; Tenney M; Christopher G; Petersen K; Endy T; Petruccelli B
Clin Infect Dis; 2007 Jun; 44(12):1577-84. PubMed ID: 17516401
[TBL] [Abstract][Full Text] [Related]
14. Acinetobacter baumannii: an emerging opportunistic pathogen.
Howard A; O'Donoghue M; Feeney A; Sleator RD
Virulence; 2012 May; 3(3):243-50. PubMed ID: 22546906
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii.
Tekin R; Dal T; Bozkurt F; Deveci O; Palanc Y; Arslan E; Selçuk CT; Hoşoğlu S
J Burn Care Res; 2014; 35(1):e73-80. PubMed ID: 23799478
[TBL] [Abstract][Full Text] [Related]
16. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
17. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.
Durante-Mangoni E; Zarrilli R
Future Microbiol; 2011 Apr; 6(4):407-22. PubMed ID: 21526942
[TBL] [Abstract][Full Text] [Related]
18. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
Prates CG; Zavascki AP
Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
[No Abstract] [Full Text] [Related]
19. Phenotypic and genetic relationship of Acinetobacter Baumannii isolates.
Trajkovska-Dokic E; Kotevska V; Kaftandzieva A; Jankoska G; Mircevska G; Petrovska M; Panovski N
Prilozi; 2011; 32(2):157-68. PubMed ID: 22286620
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
